. Author manuscript; available in PMC: 2022 Jan 15.

Published in final edited form as: J Affect Disord. 2020 Oct 7;279:417–425. doi: 10.1016/j.jad.2020.10.011

Table 1b:

The Effects of Citalopram on Depressive Symptoms and Neuropsychological Function in patients with Late-Life Depression (mean ± standard deviation)

	Patients with Late-Life Depression (n = 9) Baseline	Patients with Late-Life Depression (n = 9) During Citalopram Treatment

Hamilton Depression Rating Scale	17 ± 2^a	4 ± 2^a

Beck Depression Inventory	22 ± 8 ^b	7 ± 3^b

Mini-Mental Status Examination	29 ± 1	30 ± 1

Total California Verbal Learning Test (CVLT) Score (Sum of Trials 1–5)	54 ± 9	53 ± 10

Brief Visuospatial Memory Test, Re vis d (Sum of Trials 1–5)	18 ± 9	21 ± 7

DKEFS Letter Fluency^*	42 ± 7	42 ± 9

DKEFS Category Fluency ^*	40 ± 8	40 ± 6

D-KEFS™ = Delis-Kaplan Executive Function System™

Significant difference in the LLD patients before and during Citalopram treatment (t₈=7.7, p<0.001)

Significant difference in the LLD patients before and during Citalopram treatment (t₈=4.5, p<0.001)